In recent decades, researchers have consistently explored new ways to tackle the global obesity epidemic. While existing methods show significant results, such as the dramatic, long-term weight loss ...

More obesity patients are turning to drugs like Ozempic and Zepbound instead of having bariatric surgery. But most don't receive either treatment.

Add Yahoo as a preferred source to see more of our stories on Google. The pill forms a film on the small intestine that redirects nutrient exposure to the lower intestine and gives patients a feeling ...

A new once-daily pill may raise the bar for weight loss meds. Ozempic, Mounjaro and similar drugs that mimic the GLP-1 hormone the body naturally produces after eating can cause significant weight ...

The results of the first human trial examining a new weight loss procedure called gastric mucosal ablation were released Thursday, and the non-surgical procedure caused minimal side effects with a ...

Two of the most common bariatric procedures are gastric sleeve surgery and gastric bypass.

GLP-1s closing gap bariatric surgery with up to 30% weight loss in trials, but surgery leads in real-world outcomes and durability.

Forward-looking: The rising popularity of GLP-1 receptor agonists like Ozempic and Wegovy has transformed obesity treatment and spurred competition among pharmaceutical companies to develop more ...

From tingling, burning skin to finding even the touch of your clothes painful, along with experiencing high anxiety levels ...

People taking retatrutide lost nearly 30% of their bodyweight on average. It will likely be the most powerful weight loss drug yet — but that doesn't mean it's for everyone, experts say.